Bauer J H
Arch Intern Med. 1983 May;143(5):927-31.
Fourteen hypertensive men underwent assessment of renal function and body fluid composition following short-term (three to six weeks), long-term (five to six months), and withdrawal (two weeks) of propranolol hydrochloride monotherapy for the treatment of hypertension. Results indicate that propranolol had little effect on glomerular filtration rate (less than 10% decrease); changes that did occur were directly correlated with changes in effective renal plasma flow. Propranolol therapy decreased effective renal plasma flow 14% and renal blood flow 15% during long-term therapy; decreases in renal perfusion persisted following withdrawal of therapy. Propranolol therapy was neither antidiuretic nor antinatriuretic; propranolol had no effect on urine osmolality, free water clearance, sodium clearance, or fractional sodium excretion. Furthermore, propranolol therapy did not expand plasma volume, extracellular fluid volume, or total body water. Finally, propranolol therapy had no effect on the renal handling of potassium or on serum potassium concentration.
十四名高血压男性患者在接受盐酸普萘洛尔单一疗法治疗高血压的短期(三至六周)、长期(五至六个月)及停药(两周)后,接受了肾功能和体液成分评估。结果表明,普萘洛尔对肾小球滤过率影响很小(降低幅度小于10%);所发生的变化与有效肾血浆流量的变化直接相关。长期治疗期间,普萘洛尔疗法使有效肾血浆流量降低了14%,肾血流量降低了15%;停药后肾灌注仍持续下降。普萘洛尔疗法既不具有抗利尿作用也不具有抗利钠作用;普萘洛尔对尿渗透压、自由水清除率、钠清除率或钠排泄分数均无影响。此外,普萘洛尔疗法并未使血浆容量、细胞外液容量或总体液量增加。最后,普萘洛尔疗法对肾脏处理钾的过程或血清钾浓度均无影响。